Acquiring Company
ClearOne
Acquired Company
Cortigent
Description
Vivani's subsidiary Cortigent has entered a merger agreement with ClearOne, Inc. The combined entity will be traded under the new ticker symbol CRGT. This merger aims to establish Cortigent as a separately listed public company and allow Vivani to focus on its drug implant pipeline. It is expected to conclude in the third quarter of 2026.
Don't miss ClearOne's next move
Get an email the moment ClearOne makes an acquisition, hires an exec, or expands — usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Cortigent?
Cortigent was acquired by ClearOne, based in Salt Lake City. The deal was reported on August 15, 2026. ClearOne is a global company that designs, develops and sells conferencing, collaboration, and network streaming & signage solutions. ClearOne is publicly traded (CLRO) and operates in Information Technology.
When did ClearOne acquire Cortigent?
ClearOne's acquisition of Cortigent was reported on August 15, 2026. Vivani's subsidiary Cortigent has entered a merger agreement with ClearOne, Inc. The combined entity will be traded under the new ticker symbol CRGT. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Cortigent do?
Cortigent, Inc. is developing brain implant devices aimed at helping patients regain critical body functions. Their neurostimulation technology platform leverages neuroscience and proprietary microelectronics to create advanced medical devices. It is publicly traded (CRGT), operating in Manufacturing, and is based in United States.